Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Search results are limited to 1000 results out of 1804. Try refining your search.

Returning 1000 results: Page 1 of 40


Tier Species Size Attr. GeneSet
Tier III 19901 GS407933: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_Log2FC
Tier III 19901 GS407934: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_qvalue
Tier III 17086 GS407944: Differentially expressed genes in opioid use disorder postmortem human brain_qvalue
Tier III 17086 GS407945: Differentially expressed genes in opioid use disorder postmortem human brain_log2FC
Tier III 18513 GS407948: Differentially expressed genes in humans nucleus accumbens associated with opioid use disorder_log2FC
Tier III 18278 GS407950: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_log2FC
Tier III 18278 GS407951: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_qvalue
Tier III 19863 GS407964: Differential gene expression in human postmortem tissue samples of the dorsolateral prefrontal cortex_logFC
Tier III 19863 GS407965: Differential gene expression in human postmortem tissue samples of the dorsolateral prefrontal cortex_qvalue
Tier IV 13854 GS408212: Transcriptional differences in dorsolateral prefrontal cortex (DLPFC) and nucleus accumbens (NAc) in unaffected comparison subjects_coefficient
Tier IV 13854 GS408213: Transcriptional differences in dorsolateral prefrontal cortex (DLPFC) and nucleus accumbens (NAc) in unaffected comparison subjects_qvalue
Tier IV 13854 GS408215: Transcriptional differences in dorsolateral prefrontal cortex (DLPFC) in human opioid use disorder subjects_coefficient
Tier IV 13854 GS408217: Transcriptional differences in nucleus accumbens (NAc) in human opioid use disorder subjects_coefficient
Tier IV 169 GS408222: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Corradin et al. 2022_log2FC
Tier IV 169 GS408223: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Corradin et al. 2022_qvalue
Tier IV 87 GS408224: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Mendez et al 2021_log2FC
Tier IV 17285 GS408225: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_metaanalysis_qvalue
Tier IV 54 GS408226: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Seney et al 2021_log2FC
Tier IV 54 GS408227: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Seney et al 2021_qvalue
Tier IV 133 GS408228: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Sosnowski et al 2022_log2FC
Tier IV 133 GS408230: Differential gene expression associated with opioids in humans_dorsolateral prefrontal cortex_reanalysis of Sosnowski et al 2022_qvalue
Tier II 105 GS33875: Whole Brain Gene expression correlates of Difference in distance traveled (cm) during the first last min (saline-ethanol) in Males BXD
Tier II 68 GS34371: Whole Brain Gene expression correlates of Novel environment locomotion (activity beam breaks) 15-30 min in the center in Males BXD
Tier II 50 GS34381: Whole Brain Gene expression correlates of Novel environment locomotion (cm) 15-30 min in the center in Males BXD
Tier II 44 GS34429: Whole Brain Gene expression correlates of Novel environment vertical activity counts minutes 0-15 in Males BXD